151 related articles for article (PubMed ID: 2598192)
1. Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.
Iwahashi T; Tone Y; Usui J; Watanabe H; Sugawara I; Mori S; Okazaki H
Cancer Immunol Immunother; 1989; 30(4):239-46. PubMed ID: 2598192
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
[TBL] [Abstract][Full Text] [Related]
3. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
Lau A; Bérubé G; Ford CH; Gallant M
Bioorg Med Chem; 1995 Oct; 3(10):1305-12. PubMed ID: 8564396
[TBL] [Abstract][Full Text] [Related]
4. Internalization of an intact doxorubicin immunoconjugate.
Shih LB; Goldenberg DM; Xuan H; Lu HW; Mattes MJ; Hall TC
Cancer Immunol Immunother; 1994 Feb; 38(2):92-8. PubMed ID: 8306371
[TBL] [Abstract][Full Text] [Related]
5. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
[TBL] [Abstract][Full Text] [Related]
7. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-anti-carcinoembryonic antigen immunoconjugate activity in vitro.
Richardson VJ; Ford CH; Tsaltas G; Gallant ME
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):633-40. PubMed ID: 2714340
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J
Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968
[TBL] [Abstract][Full Text] [Related]
11. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
12. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
13. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
Levin LV; Griffin TW; Childs LR; Davis S; Haagensen DE
Cancer Immunol Immunother; 1987; 24(3):202-6. PubMed ID: 3496151
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
[TBL] [Abstract][Full Text] [Related]
15. Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.
Shih LB; Goldenberg DM; Xuan H; Lu H; Sharkey RM; Hall TC
Cancer Res; 1991 Aug; 51(16):4192-8. PubMed ID: 1868440
[TBL] [Abstract][Full Text] [Related]
16. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
17. Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice.
Shih LB; Goldenberg DM
Cancer Immunol Immunother; 1990; 31(4):197-201. PubMed ID: 1696173
[TBL] [Abstract][Full Text] [Related]
18. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
Kitagawa H; Ohkouchi E; Fukuda A; Imai K; Yachi A
Jpn J Cancer Res; 1986 Sep; 77(9):922-30. PubMed ID: 2429946
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
Blumenthal RD; Osorio L; Hayes MK; Horak ID; Hansen HJ; Goldenberg DM
Cancer Immunol Immunother; 2005 Apr; 54(4):315-27. PubMed ID: 15592930
[TBL] [Abstract][Full Text] [Related]
20. A fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft model.
Shih LB; Xuan H; Sharkey RM; Goldenberg DM
Int J Cancer; 1990 Dec; 46(6):1101-6. PubMed ID: 1701165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]